What happened
Australian medical practices, including approximately 40% of general practitioners, widely adopt AI scribes; specialists also use these tools for drafting medical records, discharge summaries, and referral letters. Dozens of companies operate in this global hundreds-of-millions-of-dollars industry. Australia's Therapeutic Goods Administration (TGA) currently excludes these tools from medical device regulation if they only transcribe, contrasting with the UK's NHS England, which mandates compliance and registration with its regulatory agency.
Why it matters
Unregulated AI scribes introduce significant patient safety and clinician liability risks. These tools can hallucinate, omit critical information, and introduce biases, potentially worsening medical care and fostering automation bias among healthcare providers. Procurement teams and legal counsel must assume current AI scribe deployments carry unmitigated patient safety, data security, and legal risks, particularly concerning informed consent and potential criminal penalties under surveillance device laws.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
